FORA Capital’s Acceleron Pharma XLRN Stock Holding History

FORA Capital’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,881	Closed	-$668K	–	512
2021 Q3	$668K	Buy	+3,881	New	+$508K	0.17%	164
2021 Q1	–	Sell	-2,440	Closed	-$312K	–	1232
2020 Q4	$312K	Buy	+2,440	New	+$286K	0.05%	404
2020 Q2	–	Sell	-3,743	Closed	-$336K	–	1432
2020 Q1	$336K	Sell	3,743 -1,209	-24%	-$94K	0.07%	319
2019 Q4	$263K	Buy	+4,952	New	+$226K	0.03%	552

FORA Capital's XLRN Position: Q4 2021 in Review

FORA Capital sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3,881 shares — an estimated $668K sold.

FORA Capital first reported a position in XLRN in Q4 2019 and held it in 4 quarters. The position peaked at $668K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

FORA Capital reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
FORA Capital sold 3,881 Acceleron Pharma shares in Q4 2021, an estimated $668K.
FORA Capital first reported a position in Acceleron Pharma in Q4 2019 and held it in 4 quarters.
FORA Capital's Acceleron Pharma position peaked at $668K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on FORA Capital's 13F filing for Q4 2021, filed 11 Feb 2022.